高血压，糖尿病，冠心病和缺血性脑血管病等慢性病的有效管理，是社区全科医生的重要工作内容，也是一个比较困难的课题。
It is an important yet a difficult task for family physicians to efficiently manage chronic diseases like hypertension, diabetes, coronary heart diseases and ischemic cerebrovascular diseases.
缺血性脑血管病是导致死亡和能力丧失的主要原因，在中国更是如此。
Ischemic Cerebral Vascular Disease is a major cause of death and disability, especially in China.
文章主要对代谢综合征的病因和其促成缺血性脑血管病的机制和治疗方面的进展作一综述。
The article mainly reviews the etiology of metabolic syndrome, the mechanism contributing to ischemic cerebrovascular diseases, as well as the progress in its treatment.
缺血性脑血管病的病死率和致残率均很高，给社会和家庭带来了巨大负担。
The mortality and disability of ischemic cerebrovascular diseases are very high, and place an enormous burden on society and families.
基质金属蛋白酶（MMP），尤其是MMP-2和MMP-9，在急性缺血性脑血管病的发病机制中起着重要作用。
Matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, play an important role in the pathogenesis of acute ischemic cerebrovascular diseases.
虽然FDA已经批准取栓器和吸栓器应用于急性缺血性脑血管病的治疗，但是这并不意味取栓器和吸栓器适用于每例患者。我认为这一点非常重要，大家需要牢记于心。
I think it is important to keep in mind that although the US FDA has approved clot retrieval devices and aspiration devices it does not mean that they are going to work in each case.
虽然FDA已经批准取栓器和吸栓器应用于急性缺血性脑血管病的治疗，但是这并不意味取栓器和吸栓器适用于每例患者。我认为这一点非常重要，大家需要牢记于心。
I think it is important to keep in mind that although the US FDA has approved clot retrieval devices and aspiration devices it does not mean that they are going to work in each case.
应用推荐